Orbis Allan Gray’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11B | Buy |
|
|||||
|
2025
Q1 | $1.24B | Buy |
|
|||||
|
2024
Q4 | $800M | Buy |
|
|||||
|
2024
Q3 | $471M | Sell |
|
|||||
|
2024
Q2 | $501M | Sell |
|
|||||
|
2024
Q1 | $497M | Buy |
|
|||||
|
2023
Q4 | $425M | Buy |
|
|||||
|
2023
Q3 | $386M | Buy |
|
|||||
|
2023
Q2 | $333M | Buy |
|
|||||
|
2023
Q1 | $317M | Buy |
|
|||||
|
2022
Q4 | $302M | Sell |
|
|||||
|
2022
Q3 | $318M | Sell |
|
|||||
|
2022
Q2 | $372M | Sell |
|
|||||
|
2022
Q1 | $645M | Sell |
|
|||||
|
2021
Q4 | $712M | Sell |
|
|||||
|
2021
Q3 | $640M | Sell |
|
|||||
|
2021
Q2 | $819M | Sell |
|
|||||
|
2021
Q1 | $886M | Sell |
|
|||||
|
2020
Q4 | $959M | Sell |
|
|||||
|
2020
Q3 | $932M | Buy |
|
|||||
|
2020
Q2 | $885M | Buy |
|
|||||
|
2020
Q1 | $709M | Buy |
|
|||||
|
2019
Q4 | $694M | Buy |
|
|||||
|
2019
Q3 | $548M | Buy |
|
|||||
|
2019
Q2 | $601M | Buy |
|
|||||
|
2019
Q1 | $561M | Sell |
|
|||||
|
2018
Q4 | $545M | Sell |
|
|||||
|
2018
Q3 | $649M | Sell |
|
|||||
|
2018
Q2 | $584M | Buy |
|
|||||
|
2018
Q1 | $533M | Sell |
|
|||||
|
2017
Q4 | $547M | Sell |
|
|||||
|
2017
Q3 | $552M | Sell |
|
|||||
|
2017
Q2 | $800M | Buy |
|
|||||
|
2017
Q1 | $674M | Buy |
|
|||||
|
2016
Q4 | $449M | Buy |
|
|||||
|
2016
Q3 | $266M | Buy |
|
|||||
|
2016
Q2 | $123M | Buy |
|
|||||
|
2016
Q1 | $10.8M | Buy |
|